These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients. Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309 [TBL] [Abstract][Full Text] [Related]
6. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill]. Morabito S; Pistolesi V; Cibelli L; Pierucci A G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959 [TBL] [Abstract][Full Text] [Related]
7. Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg. Bergner R; Hoffmann M; Riedel KD; Mikus G; Henrich DM; Haefeli WE; Uppenkamp M; Walter-Sack I Nephrol Dial Transplant; 2006 Apr; 21(4):1019-23. PubMed ID: 16311263 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study. Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of continuous renal replacement therapy in acute renal failure. Klarenbach S; Manns B; Pannu N; Clement FM; Wiebe N; Tonelli M; Int J Technol Assess Health Care; 2009 Jul; 25(3):331-8. PubMed ID: 19619352 [TBL] [Abstract][Full Text] [Related]
12. [Drugs dosing in intensive care unit during continuous renal replacement therapy]. Bourquin V; Ponte B; Saudan P; Martin PY Nephrol Ther; 2009 Nov; 5(6):533-41. PubMed ID: 19369134 [TBL] [Abstract][Full Text] [Related]
13. [Indications for continuous renal function replacement therapy]. Kes P; Ljutić D; Basić-Jukić N; Brunetta B Acta Med Croatica; 2003; 57(1):71-5. PubMed ID: 12876869 [TBL] [Abstract][Full Text] [Related]
14. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy. Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940 [TBL] [Abstract][Full Text] [Related]
15. Survival to discharge among patients treated with continuous renal replacement therapy. Wald R; Deshpande R; Bell CM; Bargman JM Hemodial Int; 2006 Jan; 10(1):82-7. PubMed ID: 16441832 [TBL] [Abstract][Full Text] [Related]
16. Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Kim Z; Goldfarb DS Nephron Clin Pract; 2010; 115(1):c1-6. PubMed ID: 20173343 [TBL] [Abstract][Full Text] [Related]